BioSpace News Archive

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the successful formulation of a COVID-19 vaccine candidate, obtained from a vaccine developer, utilizing Zosano’s microneedle patch system.

Noninvasix Appoints David J. Giarracco as CEO.

EpiVax, Inc. announces the publication of three papers focusing on malaria vaccine efficacy, in collaboration with Leidos, the University of Georgia Center for Vaccines and Immunology, the University of Oxford’s Jenner Institute, and Sanofi Pasteur’s VaxDesign Campus.

Human papillomavirus is the lead cause of several types of cancers such as vulvar cancer, penile cancer, vaginal cancer, and anal cancer among others.

Transparency Market Research has published a new report titled ‘Medical Devices Contract Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global medical devices contract manufacturing market was valued at US$ 47.5 Bn in 2017.

TMR observes that the global transdermal scopolamine market is experiencing the high competition and consolidation due to presence of strong players. Some of the key players operating in the global transdermal scopolamine market includes Baxter International Inc., Novartis AG, GlaxoSmithKline Plc, Caleb Pharmaceuticals Inc, Perrigo Co.

Chinook Therapeutics, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, announced that Chinook management is scheduled to participate in the following upcoming virtual investor conferences:

Regen BioPharma, Inc. (PINK: RGBP) and (PINK: RGBPP) is currently completing a strategic analysis of its next 5 years of growth.

Clarus Therapeutics Holdings, Inc., a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, announced it will release its third quarter 2021 financial and operating results on Thursday, November 18, 2021, after the market closes.

Zogenix announced that the compensation committee of the company’s board of directors granted inducement awards to thirteen new non-executive employees.